GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in therapeutic studies, largely due to its notable impact on controlling diseases such as second type diabetes and weight gain. Ongoing research have demonstrated that beyond glucose management, GLP-1 medications offer promise for cardiovascular health and